These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5067932)

  • 1. Studies on the effect of a liver hydrolysate on the hepatic circulation in chronic liver diseases.
    Obayashi A; Akioka H; Tazaki H
    Arzneimittelforschung; 1972 Mar; 22(3):578-80. PubMed ID: 5067932
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of hepatic blood flow in chronic liver diseases using the constant infusion technic].
    Vorobioff J; Carnovale C; Topol R; Picabea E; Villavicencio R; Tanno H; Audano M; Audano G
    Acta Gastroenterol Latinoam; 1984; 14(3):229-34. PubMed ID: 6537116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of liver hydrolysates and corticosteroids in chronic hepatitis and liver cirrhosis].
    Bakulenko EF
    Vrach Delo; 1976 Apr; (4):108-10. PubMed ID: 1007172
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS; Nikolaeva AP; Bendikov EA; Blok IuE; Sukhareva GV
    Sov Med; 1989; (7):79-81. PubMed ID: 2799537
    [No Abstract]   [Full Text] [Related]  

  • 5. [Absorption of vofaverdin by the liver in circulatory insufficiency, chronic hepatitis and liver cirrhosis].
    Fomichev VI
    Klin Med (Mosk); 1973 Oct; 51(10):94-6. PubMed ID: 4787288
    [No Abstract]   [Full Text] [Related]  

  • 6. Simultaneous measurement of effective hepatic blood flow and systemic circulation.
    Hashimoto M; Watanabe G
    Hepatogastroenterology; 2000; 47(36):1669-74. PubMed ID: 11149029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The estimation of hepatic blood flow with indocyanine green: comparison between the continuous infusion and single injection methods.
    Villeneuve JP; Huot R; Marleau D; Huet PM
    Am J Gastroenterol; 1982 Apr; 77(4):233-7. PubMed ID: 7072694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of the indocyanine green test in the diagnosis of chronic liver diseases.
    Janecki J; Kubicki S
    Pol Med J; 1969; 8(1):50-6. PubMed ID: 4889491
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of chronic liver diseases by means of an extralysate of liver.
    Kallai L; Kocić J
    Arzneimittelforschung; 1969 Jun; 19(6):1030-1. PubMed ID: 5820032
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trial of LL 650 in various hepatic diseases].
    Savoye B; Dietsch R; Chapuy M; Girard M
    J Med Lyon; 1972 May; 53(228):675-6 passim. PubMed ID: 5084113
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sense and nonsense of liver disease therapy].
    Wildhirt E
    Med Welt; 1970 Jun; 26():1175-8. PubMed ID: 5522884
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepason in the treatment of hepatocellular diseases].
    Stazka Z; Korolko A
    Pol Tyg Lek; 1970 Jul; 25(28):1062-4. PubMed ID: 5451158
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of compensated hepatopathies using Sirepar and Ripason].
    Fassati P; Fassati M
    Cas Lek Cesk; 1967 Oct; 106(43):1143-50. PubMed ID: 6077099
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alphamercaptopropionylglycine in chronic hepatopathies].
    Cacciari G; Malaguti P; Zincati GC
    Policlinico Med; 1972; 79(3):165-73. PubMed ID: 5051108
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blast transformation of lymphocytes in chronic liver diseases].
    Loginov AS; Osokina LI; Iartseva AM
    Biull Eksp Biol Med; 1972 Aug; 73(8):49-52. PubMed ID: 4635286
    [No Abstract]   [Full Text] [Related]  

  • 16. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT; Marigold JH; Thompson RP
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sirepar on experimental cirrhosis in rats.
    Szarvas F; Biliczki F
    Ther Hung; 1970; 18(3):103-6. PubMed ID: 5496809
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience in the treatment of acute and chronic hepatitis as well as of compensated and decompensated liver cirrhosis with the liver hydrolysate prohepar].
    RASBACH K
    Med Monatsschr; 1955 Apr; 9(4):232-6. PubMed ID: 14393497
    [No Abstract]   [Full Text] [Related]  

  • 19. [Circulatory conditions in the liver during chronic hepatitis and cirrhosis as reflected by various examination methods].
    Obermajer J; Kucera J; Drásilová L
    Vnitr Lek; 1975 Aug; 21(8):784-92. PubMed ID: 1162912
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experience with solcohepsyl in the treatment of chronic liver diseases].
    Güemes Diaz F
    Rev Esp Enferm Apar Dig; 1965; 24(6):761-72. PubMed ID: 5891987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.